Kalos Management’s VivoSim Labs VIVS Stock Holding History

Kalos Management’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1	Closed	-$31	–	393
2023 Q1	$31	Buy	+1	New	+$24	﹤0.01%	402

Other funds holding VIVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Kalos Management's VIVS Position: Q2 2023 in Review

Kalos Management sold out of VivoSim Labs (VIVS) in Q2 2023, closing a stake of 1 share — an estimated $31 sold.

Kalos Management first reported a position in VIVS in Q1 2023 and held it in 1 quarter. The position peaked at $31 in Q1 2023. 34 funds tracked by Wall St. Rank hold VIVS as of Q2 2023.

Kalos Management reported no remaining VivoSim Labs position as of Q2 2023 after selling out during the quarter.
Kalos Management sold 1 VivoSim Labs share in Q2 2023, an estimated $31.
Kalos Management first reported a position in VivoSim Labs in Q1 2023 and held it in 1 quarter.
Kalos Management's VivoSim Labs position peaked at $31 in Q1 2023.
34 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2023.

Based on Kalos Management's 13F filing for Q2 2023, filed 9 Aug 2023.